Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Alan X. Xiang"'
Autor:
Peggy A. Thompson, Garrick Kenneth Packard, Theodore Michels, Boreth Eam, Alan X. Xiang, Reich Siegfried Heinz, Sarah Fish, Christian Nilewski, Paul A. Sprengeler, Justin T. Ernst, Christopher J. Wegerski
Publikováno v:
Organic Letters. 22:6257-6261
Rocaglates, rocaglamides, and related flavagline natural products exert their remarkable anticancer activity through inhibition of eukaryotic initiation factor 4A (eIF4A) but generally display suboptimal drug-like properties. In our efforts to identi
Autor:
Christian Nilewski, Andres Nevarez, Sarah Fish, Boreth Eam, Alan X. Xiang, Paul A. Sprengeler, Peggy A. Thompson, Jeff Clarine, Garrick Kenneth Packard, Theodore Michels, Reich Siegfried Heinz, Christopher J. Wegerski, Justin T. Ernst, Samuel Sperry
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 47:128111
Flavaglines such as silvestrol (1) and rocaglamide (2) constitute an interesting class of natural products with promising anticancer activities. Their mode of action is based on inhibition of eukaryotic initiation factor 4A (eIF4A) dependent translat
Autor:
Alan X. Xiang, Tran Chinh Viet, Douglas E. Murphy, Yuefen Zhou, Frank Ruebsam, Sun Hee Kim, Kimkim Dao, Lian-Sheng Li, Zhongxiang Sun, Peter S. Dragovich
Publikováno v:
Tetrahedron: Asymmetry. 19:2796-2803
A 4-step synthesis of an optically active synthetic intermediate [(1 R ,2 S )-2-(4′-fluorobenzylamino)cyclopentanecarboxylic acid ethyl ester complex with ( S )-(+)-mandelic acid; compound 12 , >99% de] required for the preparation of a promising H
Autor:
Laurie A. LeBrun, Mei Tsan, Yuefen Zhou, Frank Ruebsam, Darian M. Bartkowski, Alan X. Xiang, Ruhi Kamran, Lian-Sheng Li, Richard E. Showalter, Jingjing Zhao, Rupal Patel, Matthew Lardy, Maria V. Sergeeva, Stephen E. Webber, Amit M. Shah, David Archer Ellis, Zhongxiang Sun, Mcguire Helen, Julie Blazel, Leo Kirkovsky, Daniel A. Norris, Tran Chinh Viet, Charles R. Kissinger, Thomas G. Nolan, Peter S. Dragovich, Qing Han
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 18:4628-4632
4-(1,1-Dioxo-1,4-dihydro-1lambda(6)-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-one analogs were discovered as a novel class of inhibitors of HCV NS5B polymerase. Structure-based design led to the identification of compound 3a that displayed pot
Autor:
Stephen E. Webber, Amit M. Shah, Kevin R. Steffy, James R. Appleman, Alan X. Xiang, Robert M. Aust, Thomas Doundoulakis, Richard E. Showalter, Klaus B. Simonsen, William T. Biller, Virginia N. Banh, Wes Sisson, Ricardo Lira, Konstantinos A. Agrios
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 17:6797-6800
Based upon observations from our initial findings, additional myxopyronin B analogs have been prepared and tested for in vitro inhibitory activity against DNA-dependent RNA polymerase and antibacterial activity against Escherichia coli and Staphyloco
Autor:
Alberto, Gobbi, Matthew, Lardy, Sun Hee, Kim, Frank, Ruebsam, Martin, Tran, Stephen E, Webber, Alan X, Xiang
Publikováno v:
In silico biology. 11(1-2)
We present Illuminator, a user-friendly web front end to computational models such as docking and 3D shape similarity calculations. Illuminator was specifically created to allow non-experts to design and submit molecules to computational chemistry pr
Publikováno v:
ChemInform. 30
Received July 9, 1998 Clerocidin (1),1 terpentecin (2),2 and UCT4B (3)3 (Figure 1) are recently isolated diterpenoid antibiotics that exhibit very promising antitumor activities in vitro and in vivo.4 It has been postulated that their antitumor prope
Publikováno v:
ChemInform. 31
Formation of the C11-C1' bond through application of Barton's radical decarboxylation and quinone addition is the cornerstone of a new convergent and concise synthesis of the marine metabolites avarol (1) and avarone (2; see scheme), for which antimi
Autor:
Tran Chinh Viet, Benjamin K. Ayida, Peter S. Dragovich, Amit M. Shah, Huiying J. Hou, Peggy A. Thompson, Frank Ruebsam, Jingjing Zhao, Rupal Patel, Daniel A. Norris, Ruhi Kamran, Thomas G. Nolan, Stephen E. Webber, Qing Han, Charles R. Kissinger, Alan X. Xiang, Lian-Sheng Li, Darian M. Bartkowski, Jennifer Brooks, Julia Khandurina, Ellen Okamoto, Zhongxiang Sun, Mei Tsan, Laurie A. LeBrun, Mcguire Helen, Julie K. Blazel, Maria V. Sergeeva, Sun Hee Kim, Yuefen Zhou, Douglas E. Murphy, Richard E. Showalter, Leo Kirkovsky
Publikováno v:
Bioorganicmedicinal chemistry letters. 19(22)
A novel series of non-nucleoside small molecules containing a tricyclic dihydropyridinone structural motif was identified as potent HCV NS5B polymerase inhibitors. Driven by structure-based design and building on our previous efforts in related serie
Autor:
Ruhi Kamran, Tran Chinh Viet, Laurie A. LeBrun, Alberto Gobbi, Jingjing Zhao, David Archer Ellis, Qiang Zhao, Julie Blazel, Rupal Patel, Matthew Lardy, Maria V. Sergeeva, Thomas G. Nolan, Qing Han, Stephen E. Webber, Amit M. Shah, Yuefen Zhou, Frank Ruebsam, Richard E. Showalter, Darian M. Bartkowski, Leo Kirkovsky, Alan X. Xiang, Lian-Sheng Li, Douglas E. Murphy, Mei Tsan, Mcguire Helen, Charles R. Kissinger, Daniel A. Norris
Publikováno v:
Bioorganicmedicinal chemistry letters. 19(21)
The discovery of 5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of the HCV RNA-dependent RNA polymerase (NS5B) is described. Several of these agents also display potent antiviral activity in cell culture experiments (EC50